… option for patients with aGvHD as well as cGvHD. Key Messages: ECP is a well-established
second-line therapy … towards an effective second-line therapy option. In the future ECP could …

… Extracorporeal photopheresis is one of several secondary therapies which have shown
promise in the clinical setting… of the mechanisms from which therapeutic benefits are seen, and …

… Extracorporeal photochemotherapy as single therapy for extensive, cutaneous. chronic graft-…
Extracorporeal photochemotherapy as an effective treatment modality in chronic graft-versus…

… extracorporeal photochemotherapy, extracorporeal photoimmunotherapy or just photopheresis)
is a leukapheresis-based therapy … and the limited therapeutic options for these patients, …

… alone and in combination with IFN-α, IFN-γ, or bexarotene and ECP plus bexarotene, IFN-α,
IFN-γ, or low-dose methotrexate alone or in combination are alternative therapeutic options. …

… chemotherapy and extracorporeal photochemotherapy for T3 and T4 cutaneous T-cell
lymphoma patients who have achieved a complete response to total skin electron beam therapy. …

… This apoptotic cell product is the key therapeutic mediator of … ECP's therapeutic potential and
great safety profile has … safer alternative to other therapeutic options for the conditions listed …

… Current options include the addition of various immunosuppressive agents, the use of which
… Extracorporeal photopheresis (ECP) is a widely used cellular therapy currently approved by …

… Extracorporeal photopheresis is a recommended therapy for the first-line treatment of …
A study is now underway to investigate the efficacy of ECP as a therapeutic option for BO(S) …

… Extracorporeal photopheresis (ECP) is a therapy that … changed the position of ECP in the
therapy of GVHD and has started to … listed 14 different therapeutic options to choose from [36]. …